Moderate to Severe Ulcerative Colitis research hub

A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis

This study is looking into a new medicine called Vixarelimab for people with moderate to severe ulcerative colitis. It aims to see how the medicine works in the gut and if it is safe. Researchers want to understand if it could be a helpful new treatment option.